Skip to main content

Table 1 Characteristics of studies included in meta-analysis on sarcopenia with steatohepatitis and liver fibrosis

From: Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis

Year First Author Design NAFLD (N)/ Total (N) Country Age (Years) Gender (% Male) Method of diagnosis of sarcopenia Method of diagnosis of NAFLD Method of diagnosis of liver fibrosis Study quality1
2017 Petta [12] Cross-sectional 225/225 Italy 48.3 62.7 BIA Liver biopsy Liver biopsy 8
2017 Koo [13] Cross-sectional 240/309 Korea 53 46.9 BIA Liver biopsy Liver biopsy 9
2016 Lee [15]a Cross-sectional 2761/2761 Korea 55.8 55 DXA NLFS [32] NFS [33] 6
  1. BIA, Bioelectric impedance analysis, DXA Dual energy X-ray absorptiometry, LSM liver stiffness measurement, NLFS NAFLD liver fat score, NFS The NAFLD fibrosis score
  2. aNAFLD and liver fibrosis was defined using different prediction models, data of the first method was caculated and presented
  3. 1Methodological quality of included studies assessed using a method based in the 9-star Newcastle-Ottawa Scale